Quintet Private Bank (Europe)’s Editas Medicine EDIT Stock Holding History

Quintet Private Bank (Europe)’s Portfolio EDIT Stock Details EDIT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-6	Closed	-$12	–	191
2025 Q4	$12	Buy	+6	New	+$17	﹤0.01%	197

Other funds holding EDIT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Quintet Private Bank (Europe)'s EDIT Position: Q1 2026 in Review

Quintet Private Bank (Europe) sold out of Editas Medicine (EDIT) in Q1 2026, closing a stake of 6 shares — an estimated $12 sold.

Quintet Private Bank (Europe) first reported a position in EDIT in Q4 2025 and held it in 1 quarter. The position peaked at $12 in Q4 2025. 208 funds tracked by Wall St. Rank hold EDIT as of Q1 2026.

Quintet Private Bank (Europe) reported no remaining Editas Medicine position as of Q1 2026 after selling out during the quarter.
Quintet Private Bank (Europe) sold 6 Editas Medicine shares in Q1 2026, an estimated $12.
Quintet Private Bank (Europe) first reported a position in Editas Medicine in Q4 2025 and held it in 1 quarter.
Quintet Private Bank (Europe)'s Editas Medicine position peaked at $12 in Q4 2025.
208 funds tracked by Wall St. Rank held Editas Medicine as of Q1 2026.

Based on Quintet Private Bank (Europe)'s 13F filing for Q1 2026, filed 22 Apr 2026.